2025

Zang W (D2), Koike Y, Nishimura K, Tanaka A, Yamazaki H, Yamasaki T, Ito H, Zhang Y, Aoyama Y, Saika W, Xiao M, Hasegawa C, Kunimoto H, Nakajima H, Ishikawa F, Takaori-Kondo A, Inoue D. BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemia. Scientific Reports. 2025 Oct 23;15(1):37099.
https://pubmed.ncbi.nlm.nih.gov/41131284/
Aoyama Y (D4), Yamazaki H, Nishimura K, Nomura M, Shigehiro T, Suzuki T, Zang W, Tatara Y, Ito H, Hayashi Y, Koike Y, Fukumoto M, Tanaka A, Zhang Y, Saika W, Hasegawa C, Kasai S, Kong Y, Minakuchi Y, Itoh K Professor, Yamamoto M, Toyokuni S, Toyoda A, Ikawa T, Takaori-Kondo A, Inoue D. Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature Lineages. Blood. 2025 Mar 13;145(11):1149-1163.
https://pubmed.ncbi.nlm.nih.gov/39775457/
Zhang Y (D4), Nomura M, Nishimura K, Zang W, Koike Y, Xiao M, Ito H, Fukumoto M, Tanaka A, Aoyama Y, Saika W, Hasegawa C, Yamazaki H, Takaori-Kondo A, Inoue D. In-Depth Functional Analysis of BRD9 in Fetal Hematopoiesis Reveals Context-Dependent Roles. iScience. 2025 Feb 12;28(3):112010.
https://pubmed.ncbi.nlm.nih.gov/40109374/
Hirayama M, Hatou S, Nomura M, Hokama R, Hirayama, O-I, Inagaki E, Aso K, Sayano T, Dohi H, Hanatani T, Takasu N, Okano H, Negishi K, Shimmura S. A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy. Cell Rep Med. 2025 Jan;6(1):101847.
https://pubmed.ncbi.nlm.nih.gov/39809262/